Biocon Biologics Inc.

26 active products from this manufacturer.

Compare NDC listings and package configurations, then submit RFQ requests for facility procurement review.

Need a Product Not Listed?

Submit a custom quote request for unlisted NDCs, item codes, or alternate product presentations.

Drug Catalog Search | Request a Custom Quote

Manufacturer scope

This manufacturer hub consolidates exact-item pages from Biocon Biologics Inc.so healthcare teams can review the catalog footprint before narrowing into the exact NDC presentation they need.

Indexed footprint: 26 active products.
Common generics: adalimumab-fkjp, bevacizumab-nwgd, Denosumab-kyqq, and insulin aspart-xjhz.
Dosage forms shown: Kit, Injection, and Solution.
Product-NDC families: 83257-0016, 83257-0020, 83257-0017, and 83257-0019.

How to use this page

Manufacturer hubs help with qualification and sourcing research, but exact-item intent still belongs on the child NDC pages. Use this manufacturer view to identify the right product family, then click into the exact NDC row for package-level details.

Showing page 1 of 1


adalimumab-fkjp Kit 0.4 mL (Hulio)	83257-0016-42	adalimumab-fkjp	-	Kit
adalimumab-fkjp Kit 0.4 mL	83257-0020-42	adalimumab-fkjp	-	Kit
adalimumab-fkjp Kit 0.8 mL (Hulio)	83257-0017-42	adalimumab-fkjp	-	Kit
adalimumab-fkjp Kit 0.8 mL (Hulio)	83257-0019-32	adalimumab-fkjp	-	Kit
adalimumab-fkjp Kit 0.8 mL	83257-0021-42	adalimumab-fkjp	-	Kit
adalimumab-fkjp Kit 0.8 mL	83257-0022-32	adalimumab-fkjp	-	Kit
bevacizumab-nwgd 25 mg / mL Injection 16 mL (Jobevne)	83257-0010-11	bevacizumab-nwgd	25 mg / mL	Injection
bevacizumab-nwgd 25 mg / mL Injection 4 mL (Jobevne)	83257-0009-11	bevacizumab-nwgd	25 mg / mL	Injection
Denosumab-kyqq 120 mg / 1.7mL Injection 1.7 mL (Aukelso)	83257-0030-11	Denosumab-kyqq	120 mg / 1.7mL	Injection
Denosumab-kyqq 60 mg / mL Injection 1 mL (Bosaya)	83257-0029-41	Denosumab-kyqq	60 mg / mL	Injection
insulin aspart-xjhz 100 [iU] / mL Injection 10 mL (Kirsty)	83257-0007-11	insulin aspart-xjhz	100 [iU] / mL	Injection
insulin aspart-xjhz 100 [iU] / mL Injection 3 mL (Kirsty)	83257-0008-32	insulin aspart-xjhz	100 [iU] / mL	Injection
insulin glargine-yfgn 100 [iU] / mL Injection 10 mL (Semglee) View in Drug Shortage Index	83257-0011-11	insulin glargine-yfgn	100 [iU] / mL	Injection
insulin Glargine-yfgn 100 [iU] / mL Injection 10 mL View in Drug Shortage Index	83257-0014-11	insulin Glargine-yfgn	100 [iU] / mL	Injection
insulin glargine-yfgn 100 [iU] / mL Injection 3 mL (Semglee)	83257-0012-31	insulin glargine-yfgn	100 [iU] / mL	Injection
insulin glargine-yfgn 100 [iU] / mL Injection 3 mL (Semglee) View in Drug Shortage Index	83257-0012-33	insulin glargine-yfgn	100 [iU] / mL	Injection
insulin Glargine-yfgn 100 [iU] / mL Injection 3 mL	83257-0015-31	insulin Glargine-yfgn	100 [iU] / mL	Injection
insulin Glargine-yfgn 100 [iU] / mL Injection 3 mL	83257-0015-32	insulin Glargine-yfgn	100 [iU] / mL	Injection
pegfilgrastim-jmdb 6 mg / .6mL Injection 0.6 mL (Fulphila)	83257-0005-41	pegfilgrastim-jmdb	6 mg / .6mL	Injection
trastuzumab-dkst 150 mg / 7.4mL Injection 15 mL (Ogivri)	83257-0001-11	trastuzumab-dkst	150 mg / 7.4mL	Injection
trastuzumab-dkst Kit 1 Kit (Ogivri)	83257-0004-12	trastuzumab-dkst	-	Kit
ustekinumab 130 mg / 26mL Solution 26 mL (Yesintek)	83257-0026-11	ustekinumab	130 mg / 26mL	Solution
ustekinumab 45 mg / .5mL Injection 0.5 mL (Yesintek)	83257-0023-41	ustekinumab	45 mg / .5mL	Injection
ustekinumab 45 mg / .5mL Injection 0.5 mL (Yesintek)	83257-0024-11	ustekinumab	45 mg / .5mL	Injection
ustekinumab 90 mg / mL Injection 1 mL (Yesintek)	83257-0025-41	ustekinumab	90 mg / mL	Injection
water 1 mL / mL Injection 10 mL (INSULIN DILUTING MEDIUM FOR Kirsty)	83257-0006-11	water	1 mL / mL	Injection

Page 1 of 1

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.